UCSF Helen Diller Family Comprehensive Cancer Center

Zena Werb, PhD

Professor and Vice-Chair, Anatomy, UCSF
Member, Biomedical Sciences Program (BMS), Herbert Boyer Program in Biological Sciences (PIBS), and Immunology Graduate Program, UCSF

CONTACT

zena.werb@ucsf.edu
(415) 476-4622, 476-4758 (voice)
(415) 476-4564 (voice), 476-0616 (fax)

Box 0452, UCSF; San Francisco, CA 94143-0452

additional websites:

Werb Lab Website

EDUCATION

University of Toronto, Toronto, Canada, B.Sc., 1966, Biochemistry
Rockefeller University, New York, NY, Ph.D., 1971, Cell Biology
Strangeways Research. Laboratory, Cambridge, U.K., Postdoc., 1971-73, Protein Chemistry

PROFESSIONAL EXPERIENCE

1973-1975

Research Scientist, Strangeways Res. Lab., Cambridge, U.K.

1975-1976

Visiting Assistant Professor of Medicine, Dartmouth Medical School, Hanover, NH

1976-1980

Asst. Professor of Radiobiology, Radiology, Univ. of California, San Francisco

1979-1980

Asst. Professor of Anatomy, UCSF

1980-1983

Assoc. Professor of Anatomy and Radiology, UCSF

1983-present

Professor of Anatomy, UCSF

1985-1986

Visiting Prof. (Lab. of N.J. Proudfoot), Sir William Dunn School of Pathology, Univ. of Oxford, U.K.

1998

Visiting Professor, Institut Curie Paris

1999-present

Vice-chair, Dept of Anatomy, UCSF

2006-7

Visiting Professor, Max-Planck Institute for Biochemistry, Martinsried, Germany

HONORS & AWARDS

(partial list)

1971-1973

Fellow, Medical Research Council of Canada

1982

R.R. Bensley Memorial Lecturer of the American Association of Anatomists

1985-1986

Fellow, John Simon Guggenheim Foundation

1986

Muriel Trotter Lecturer, Washington University, St. Louis

1993-1994

Sigma Xi National Lecturer

1996

FASEB Excellence in Science Award

1997

Chitra Biswas Memorial Lecturer, Tufts Medical School

1998

Rothschild/Mayent Fellowship, Institut Curie, Paris

1998

Earl Benditt Distinguished Lecturer, University of Washington

1999

J.L. Melnick Lecturer, Baylor College of Medicine

1999

Biosciences Distinguished Lecturer, Lawrence Berkeley National Laboratory

2000

Gwendolyn J. Stewart Award, Temple University

2001

Charlotte Friend Lecturer, AACR

2001

44th Faculty Research Lecturer, UCSF

2001

H.B. Parker Lecture, Pacific Northwest National Laboratory

2002

elected Member, Institute of Medicine

2003

elected Fellow, American Academy of Arts and Sciences

2003

Doctor of Medicine (honoris causa), University of Copenhagen

2004

Schlessinger Lecture, Beth Israel Deaconess Medical Center, Harvard Medical School

2004

A. S. Wiener Lecture, New York Blood Center

2005

Maud L. Menten Lecturer, University of Pittsburgh

2006

Alexander von Humboldt Research Award.

SELECTED PUBLICATIONS

(of more than 280 in Pubmed, 380 total full publications)

Werb, Z., P.M. Tremble, O. Behrendtsen, E. Crowley & C.H. Damsky (1989). Signal transduction through the fibronectin receptor induces metalloproteinase gene expression. J. Cell Biol. 109: 877-889. PMID: 2547805

Sympson, C.J., R.S. Talhouk, et al. (1994). Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J. Cell Biol. 125: 681-693. PMID: 8175886

Vu, T. H., J. M. Shipley, et al. (1998). MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell. 93:411-422. PMID: 9590175

Sternlicht, M. D., A. Lochter, et al. (1999). The stromal proteinase MMP-3/stromelysin-1 promotes mammary carcinogenesis. Cell. 98: 137-146. PMID: 10428026

Bergers, G., R. Brekken, et al. (2000). Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nature Cell Biol. 2: 737-744. PMID: 11025665

Coussens, L. M., C. L. Tinkle, D. Hanahan & Z. Werb (2000). MMP-9 supplied by bone marrow-derived cells regulates skin carcinogenesis. Cell. 103: 481-490. PMID: 11081634

Coussens, L. M. & Z. Werb (2002). Inflammation and cancer. Nature 420:860-867. PMID: 12490959

Egeblad, M. & Z. Werb (2002). New functions for the matrix metalloproteinases in cancer progression. Nature Rev. Cancer 2: 163-176. PMID: 11990853

Heissig, B., K. Hattori, et al. (2002). Mobilization of stem cells from the bone marrow niche requires MMP-9-mediated release of Kit ligand. Cell. 109: 625-637. PMID: 12062105

Weaver, V. M., S. Lelivre, et al. (2002). ƒÀ4 Integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell. 2: 205-216. PMID: 12242153

Wiseman, B. & Z. Werb (2002). Stromal effects on mammary gland development and breast cancer. Science. 296:1046-1049. PMID: 12004111

Yan, Y., K. Shirakabe & Z. Werb (2002). The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G-protein coupled receptors.J. Cell Biol. 158:221-226.PMID: 12119356

Colnot, C., Z. Thompson, T. Miclau, Z. Werb & J. A. Helms (2003). Altered bone regeneration in the absence of MMP9. Development. 130: 4123-4133. PMID: 12874132

Hamano, H., M. Zeisberg, et al. (2003). Physiological levels of tumstatin, a fragment of collagen IV ƒ¿3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via ƒ¿VƒÀ integrin. Cancer Cell. 3:589-601. PMID: 12842087

Li, Y., B. Welm, et al. (2003). Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc. Natl. Acad. Sci. USA. 100: 15853-15858. PMID: 14668450

Parisi, T., A. R. Beck, et al. (2003). Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells. EMBO J. 22: 4794-4803. PMID: 12970191

Wiseman, B.S., M. D. Sternlicht, et al. (2003). Site-specific positive and negative activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. J. Cell Biol. 162:1123-1133.PMID: 12975354

Chantrain, C. F., H. Shimada, et al. (2004). Stromal matrix metalloproteinase-9 (MMP-9) regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment. Cancer Res. 64: 1675-1686. PMID: 14996727

Cases, S., P. Zhou, et al. (2004). Development of the mammary gland requires DGAT1 expression in stromal and epithelial tissues. Development. 131: 3047-3055. PMID: 15163627

Stickens, D., D. J. Behonick, et al. (2004). Altered endochondral bone formation in matrix metalloproteinase-13 deficient mice. Development. 131: 5883-5895. PMID: 15539485

Atabai K., R. Fernandez, et al. (2005). Mfge8 is critical for mammary gland remodeling during involution. Mol. Biol. Cell. 16:5528-5537. PMID: 16195353

Carlson, T. R., Y. Yan, et al. (2005). Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice. Proc. Nat. Acad. Sci. USA 102: 9884-9889. PMID: 15994223

Heissig, B., S. Rafii, et al. (2005). Low-dose irradiation promotes tissue revascularization through Kit-ligand mediated release of VEGF from mast cells and MMP-9 mediated mobilization of endothelial progenitors. J. Exp. Med. 202:739-750. PMID: 16157686

Littlepage, L.E., M. Egeblad & Z. Werb (2005). Coevolution of cancer and stromal cellular responses. Cancer Cell. 7:499-500. PMID: 15950897

Liu, Z., X. Zhou, L. A. Diaz, R. M. Senior & Z. Werb (2005). Synergy between a plasminogen cascade and MMP-9 in autoimmune disease. J. Clin. Invest. 115: 879-887. PMID: 15841177

Morimoto-Tomita, M., K. Uchimura, et al. (2005). Sulf-2, an extracellular heparan sulfate endosulfatase, is upregulated during breast cancer progression and is proangiogenic. Neoplasia. 7: 1001-1010. PMID: 16331886

Ortega, N., D. J. Behonick, C. Colnot, D. H. Cooper & Z. Werb (2005). Galectin-3 is a downstream regulator of MMP-9 function during endochondral bone formation. Mol. Biol. Cell. 16: 3028-3039. PMID: 15800063

Radisky, D. C., D. D. Levy, et al. (2005). Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature. 436:123-127. PMID: 16001073

Song, S., A. J. Ewald, W. Stallcup, Z. Werb & G. Bergers (2005). PDGFR+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nature Cell. Biol. 7: 870-879. PMID: 16113679

Sternlicht, M.D., S.W. Sunnarborg, H. Kouros-Mehr, Y. Yu, D. C. Lee & Z. Werb (2005). Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin. Development. 132:3923-3933. PMID: 16079154

Stickens, D., B. M. Zak, N. Rougier, J. D. Esko & Z. Werb (2005). Mice deficient in Ext2 lack heparan sulfate and develop exostoses. Development. 132:5055-5068. PMID: 16236767

Wall, S., E. Werner, Z. Werb & Y. A. DeClerck (2005). Discoidin domain receptor 2 mediates tumor cell cycle arrest induced by fibrillar collagen. J. Biol. Chem. 280:40187-4019. PMID: 16186104

Greenlee, K., D. B. Corry, et al. (2006). Proteomics identification of in vivo substrates for matrix metalloproteinases 2 and 9 reveals a mechanism for resolution of inflammation. J. Immunol. 177: 7312-7321. PMID: 17082650

Hsu, J.-Y. C., R. McKeon, et al. (2006). Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury. J. Neurosci. 26 :9841-9850. PMID: 17005848

Kouros-Mehr, H. & Z. Werb (2006). Candidate regulators of mammary branching morphogenesis identified by genome-wide transcript analysis. Dev. Dyn. Oct 12; [Epub ahead of print] PMID: 17039550

Kouros-Mehr, H., E. M. Slorach, M. D. Sternlicht & Z. Werb (2006). GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell. In press.

Lum, D.H., J. Tan, S. D. Rosen & Z. Werb (2006). Gene trap disruption of the mouse heparan sulfate 6-O-endosulfatase, Sulf2. Mol. Cell. Biol. In press.

Lund, L.R., K. A. Green, et al. (2006). Plasminogen activation independent of uPA and tPA maintains skin wound healing in gene-deficient mice. EMBO J. 25:2686-2697. PMID: 16763560

Sternlicht, M.D., H. Kouros-Mehr, P. Lu & Z. Werb (2006). Hormonal and local control of mammary branching morphogenesis. Differentiation. 74:365-381. PMID: 16916375

Sternlicht, M. D., A. M. Dunning, et al. (2006). Prognostic value of PAI1 in invasive breast cancer: evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expression. Canc. Epidemiol. Biomarkers. Prev. In press.

Uchimura, K., M. Morimoto-Tomita, et al. (2006). HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1 and SDF-1. BMC Biochemistry. 7:2. PMID: 16417632

Zeisberg, M., M. Khurana, et al. (2006). Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease. PLoS Med. 3:e100. PMID: 16509766

12/7/06

Return

Copyright © 2009 University of California Regents. All Rights Reserved.
UCSF Helen Diller Family Comprehensive Cancer Center

 

 

This site will look much better in a browser that supports web standards, but it is accessible to any browser or Internet device. Please upgrade your browser.